The Discounted Cash Flow (DCF) valuation of Mersana Therapeutics Inc (MRSN) is (6.05) USD. With the latest stock price at 0.34 USD, the upside of Mersana Therapeutics Inc based on DCF is -1862.6%.
Based on the latest price of 0.34 USD and our DCF valuation, Mersana Therapeutics Inc (MRSN) is a sell. selling MRSN stocks now will result in a potential gain of 1862.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 9.8% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (30.09) - (3.32) | (6.05) |
| Upside | -8872.5% - -1067.6% | -1862.6% |